Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
OSAKA UNIVERSITY	SUITA-SHI OSAKA 565-0871

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....
• A61P:THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDI....

• 2017 Application Filing Year
• A61K Class
• 21227 Applications Filed
• 12841 Patents Issued To-Date
• 60.50 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Ikeda, Yuka	Osaka, JP	5	29
# of filed Patents : 5 Total Citations : 29
Koriyama, Hiroshi	Osaka, JP	21	114
# of filed Patents : 21 Total Citations : 114
Morishita, Ryuichi	Osaka, JP	102	524
# of filed Patents : 102 Total Citations : 524
Nakagami, Hironori	Osaka, JP	34	76
# of filed Patents : 34 Total Citations : 76
Shimamura, Munehisa	Osaka, JP	8	8
# of filed Patents : 8 Total Citations : 8

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 0 Citation Count
• A61K Class

• 0 % this patent is cited more than
• 6 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
7.5 Year Payment	$3600.00	$1800.00	$900.00	Jun 5, 2027
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Jun 5, 2031

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 7.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

Full Text

US Patent Application No: 2019/0365,859

PROPHYLACTIC OR THERAPEUTIC AGENT FOR INFLAMMATORY SKIN DISEASE

---

Abstract

---

The present invention provides a preventive or therapeutic agent for an inflammatory skin disease, such as psoriasis, the agent comprising an oligopeptide as an active ingredient. More specifically, the invention provides a preventive or therapeutic agent for an inflammatory skin disease, the agent comprising an oligopeptide consisting of an amino acid sequence containing a DE loop sequence of RANKL protein and a β-strand D sequence of RANKL protein placed adjacent to the N-terminal side of the DE loop sequence.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

• No Legal Status data available.